Contrarily, FLRT2 downregulation was observed in colorectal cancer and breast cancer, and FLRT2 inhibited colorectal cancer (Guo et al., 2020) and breast cancer (Bae et al., 2017) progression. This evidence concerns the gene FLRT2 and colorectal cancer.